Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peyman Hadji

Showing results (1-10 of 171) with videos related to

Pageof 18
Sort By:
Critical Reviews in Oncology/Hematology|March 21, 2009
Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapyPeyman Hadji
Breast Care (Basel, Switzerland)|July 23, 2011
Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase InhibitorPeyman Hadji
Critical Reviews in Oncology/Hematology|April 23, 2011
Clinical considerations for the use of antiresorptive agents in the treatment of metastatic bone diseasePeyman Hadji
Critical Reviews in Oncology/Hematology|September 2, 2008
Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosisPeyman Hadji
Nature Reviews. Clinical Oncology|March 28, 2012
Breast cancer: Aromatase inhibitors--bone health assessment is crucialPeyman Hadji
Pharmazie in Unserer Zeit|October 23, 2004
[When is hormone therapy useful?]Peyman Hadji
Bonekey Reports|June 2, 2015
Cancer Treatment-Induced Bone Loss in women with breast cancerPeyman Hadji
Breast Cancer Research : BCR|December 22, 2010
Prevention of bone metastases and management of bone health in early breast cancerMichael Gnant, Peyman Hadji
Therapeutische Umschau. Revue Therapeutique|September 24, 2021
[Update on fracture prevention after menopause]Friederike Thomasius, Peyman Hadji
Der Unfallchirurg|June 8, 2019
[Influence of hormone or hormone replacement therapy on bone healing]Friederike Thomasius, Peyman Hadji
Pageof 18

Showing results (1-10 of 171) with videos related to

Sort By:
Pageof 18
Critical Reviews in Oncology/Hematology|March 21, 2009
Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapyPeyman Hadji
Breast Care (Basel, Switzerland)|July 23, 2011
Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase InhibitorPeyman Hadji
Critical Reviews in Oncology/Hematology|April 23, 2011
Clinical considerations for the use of antiresorptive agents in the treatment of metastatic bone diseasePeyman Hadji
Critical Reviews in Oncology/Hematology|September 2, 2008
Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosisPeyman Hadji
Nature Reviews. Clinical Oncology|March 28, 2012
Breast cancer: Aromatase inhibitors--bone health assessment is crucialPeyman Hadji
Pharmazie in Unserer Zeit|October 23, 2004
[When is hormone therapy useful?]Peyman Hadji
Bonekey Reports|June 2, 2015
Cancer Treatment-Induced Bone Loss in women with breast cancerPeyman Hadji
Breast Cancer Research : BCR|December 22, 2010
Prevention of bone metastases and management of bone health in early breast cancerMichael Gnant, Peyman Hadji
Therapeutische Umschau. Revue Therapeutique|September 24, 2021
[Update on fracture prevention after menopause]Friederike Thomasius, Peyman Hadji
Der Unfallchirurg|June 8, 2019
[Influence of hormone or hormone replacement therapy on bone healing]Friederike Thomasius, Peyman Hadji
Pageof 18